Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04484818 |
|---|---|
| Brief Title: | Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study |
| First Submitted : | July 21, 2020 |
| First Submitted that Met QC Criteria : | July 23, 2020 |
| First Posted : | July 24, 2020 |
| Last Update Submitted that Met QC Criteria : | June 21, 2023 |
| Last Update Posted : | June 23, 2023 |